Viewing Study NCT01549834


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-03-17 @ 6:34 AM
Study NCT ID: NCT01549834
Status: COMPLETED
Last Update Posted: 2014-10-31
First Post: 2012-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module